TENX 13G

Company

TENAX THERAPEUTICS, INC.

Filed

February 5, 2019

Accession Number

0001393825-19-000103

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →